11 recruiting, 10 completed, 7 active not recruiting, 7 terminated. 41 Phase 1, 15 Phase 2.
Follow 5fu: new trials by email Literature Review of 5fu trials Research Report on 5fu
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing Safe Doses of Anti-Cancer Medicines, 5-Flurouracil (5-FU) and Tretinoin (ATRA), Added to the Usual Cancer Treatment of Ependymoma Biospecimen Collection, Echocardiography Test, Fluorouracil - Childhood Posterior Fossa Ependymoma | Phase 1 / Phase 2 | Not yet recruiting | Children's Oncology Group | 70 | 2026-12-11 | 2026-09-30 |
| Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer Biospecimen Collection, Computed Tomography, Fluorouracil - Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma | Phase 1 | Not yet recruiting | City of Hope Medical Center | 30 | 2026-12-01 | 2026-09-02 |
| DCE-MRI for Neoadjuvant Treatment Assessment in Patients With Borderline Resectable Pancreatic Cancer Biospecimen Collection, Computed Tomography, Dynamic Contrast-Enhanced Magnetic Resonance Imaging - Borderline Resectable Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | Recruiting | Ohio State University Comprehensive Cancer Center | 50 | 2026-10-01 | 2026-10-05 |
| AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer Biopsy Procedure, Cisplatin, Computed Tomography - Borderline Resectable Pancreatic Ductal Adenocarcinoma, Locally Advanced Cholangiocarcinoma | Phase 1 | Recruiting | Jonsson Comprehensive Cancer Center | 46 | 2026-05-29 | 2026-08-20 |
| Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy Biospecimen Collection, Capecitabine, Diltiazem Hydrochloride - Malignant Digestive System Neoplasm | Phase 1 / Phase 2 | Recruiting | Mayo Clinic | 60 | 2026-04-30 | 2026-06-02 |
| Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 | Phase 1 / Phase 2 | Recruiting | Roswell Park Cancer Institute | 35 | 2026-02-16 | 2026-08-19 |
| Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers Capecitabine, Docetaxel, Fluorouracil - Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8 | Phase 1 | Withdrawn | Ohio State University Comprehensive Cancer Center | 2025-12-31 | 2025-02-07 | |
| Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer Bevacizumab, Biopsy Procedure, Biospecimen Collection - Metastatic Colorectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v8 | Phase 1 | Recruiting | National Cancer Institute (NCI) | 24 | 2025-06-23 | 2026-09-09 |
| Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer Abemaciclib, Biopsy Procedure, Biospecimen Collection - Metastatic Microsatellite Stable Colorectal Carcinoma, Refractory Microsatellite Stable Colorectal Carcinoma | Phase 1 | Recruiting | National Cancer Institute (NCI) | 39 | 2025-04-18 | 2026-10-15 |
| Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer Biopsy, Biospecimen Collection, Computed Tomography - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Peritoneum | Phase 1 | Active not recruiting | Arjun Mittra | 9 | 2024-12-31 | 2026-10-09 |
| Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis Aldesleukin, Biopsy Procedure, Biospecimen Collection - Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma | Phase 1 | Active not recruiting | Mayo Clinic | 15 | 2023-11-29 | 2026-07-01 |
| FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer Balstilimab, Bevacizumab, Biospecimen Collection - Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma | Phase 1 / Phase 2 | Active not recruiting | City of Hope Medical Center | 20 | 2023-05-03 | 2026-09-01 |
| Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma Biospecimen Collection, Computed Tomography, Core Biopsy - Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | Recruiting | Jonsson Comprehensive Cancer Center | 141 | 2023-03-07 | 2026-11-09 |
| Intralesional 5-fluorouracil Injection for the Treatment of Oral Leukoplakia 5-fluorouracil - Oral Leukoplakia | Phase 1 | Withdrawn | University of California, San Francisco | 2022-09-30 | 2022-09-22 | |
| Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer Gemcitabine Hydrochloride, Nab-paclitaxel, Fluorouracil - Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | Active not recruiting | Flemming Forsberg | 120 | 2021-12-06 | 2025-11-04 |
| Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines Biopsy Procedure, Biospecimen Collection, Diagnostic Imaging Testing - Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 10 | 2021-08-13 | 2026-11-13 |
| Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Bevacizumab, Fluorouracil, Leucovorin Calcium - Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8 | Phase 1 | Completed | Ning Jin | 13 | 2021-04-02 | 2025-03-28 |
| Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer Capecitabine, Fluorouracil, Intensity-Modulated Radiation Therapy - Locally Advanced Rectal Carcinoma, Rectal Adenocarcinoma | Phase 1 | Recruiting | Jonsson Comprehensive Cancer Center | 25 | 2021-02-11 | 2026-11-05 |
| Neoadjuvant Therapy in Biliary Adenocarcinoma Gemcitabine, Cisplatin, Fluorouracil - Cholangiocarcinoma, Biliary Cancer | Phase 1 | Withdrawn | Jordan Kharofa | 2021-02-04 | 2022-04-20 | |
| Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer Fluorouracil, Nivolumab, Recombinant Interferon Alpha 2b-like Protein - Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8 | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 4 | 2021-01-13 | 2026-11-03 |
Showing 20 of 41. Sign in to see all of them.
Colorectal Neoplasms (12) · Pancreatic Neoplasms (8) · Rectal Neoplasms (6) · Neoplasm Metastasis (4) · Stomach Neoplasms (4) · Colonic Neoplasms (3) · Cholangiocarcinoma (2) · Gastrointestinal Neoplasms (2) · Melanoma (2) · Ovarian Neoplasms (2) · Squamous Cell Carcinoma of Head and Neck (2) · Adenocarcinoma (1) · Anemia (1) · Anus Neoplasms (1) · Appendiceal Neoplasms (1)
M.D. Anderson Cancer Center (6) · National Cancer Institute (NCI) (5) · City of Hope Medical Center (3) · Jonsson Comprehensive Cancer Center (3) · UNC Lineberger Comprehensive Cancer Center (3) · Mayo Clinic (2) · Ohio State University Comprehensive Cancer Center (2) · Academic and Community Cancer Research United (1) · Anne Noonan (1) · Arjun Mittra (1) · Brown University (1) · Celgene (1) · Children's Oncology Group (1) · David Adelstein (1) · David Bajor, MD (1)
United States (38) · France (1) · Norway (1) · United Kingdom (1)
Marwan G Fakih (2) · Adam J Esbenshade (1) · Ann Raldow (1) · Anne M Noonan, MBBChBAO, MSc (1) · Arjun Mittra, MD (1) · Aung Naing, MD (1) · Autumn McRee, MD (1) · Bert H. O'Neil, MD (1) · Brian D Badgwell (1) · Christine M. Walko, PharmD, BCOP (1) · Christos Fountzilas (1) · Chrystal Louis, MD (1) · David Bajor, MD (1) · David Cunningham, MD FRCP (1) · David J. Adelstein, MD (1)
PMID 24819684, PMID 25117066, PMID 29159476, PMID 33142018, PMID 33909232, PMID 34272087, PMID 34562230, PMID 34965890, PMID 37129197, PMID 39816915, PMID 39841295, PMID 39863139, PMID 39945382, PMID 41133726
P30CA033572 (3), P30CA016086 (2), UM1CA186690 (2), 2016 (1), N01CM62201 (1), P30CA015083 (1), P30CA016672 (1), P30CA043703 (1), P50CA121973 (1), R01CA199646 (1), R01CA290435 (1), R21CA282536 (1), U10CA031946 (1), U10CA180821 (1), U10CA180886 (1)